Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Headache Caused by Giant Cell Arteritis.

Thomas N Ward1, Morris Levin, Robert L Wong

  • 1Section of Neurology, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA. Thomas.N.Ward@hitchcock.org.

Current Treatment Options in Neurology
|October 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Memoriam: Neil Raskin MD, FAHS, FAAN (1935-2026).

Headache·2026
Same author

Transcultural headache medicine: A framework for integrating cultural contexts into headache science and care - a call to action from the International Headache Society.

Cephalalgia : an international journal of headache·2026
Same author

Calcitonin gene-related peptide in the audiovestibular system.

Headache·2025
Same author

2025 AHS DEI awardee: Dr. Jerome Goldstein (1941-2023).

Headache·2025
Same author

Early treatment in migraine - A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society.

Cephalalgia : an international journal of headache·2025
Same author

Reaching international consensus on the definition of refractory migraine using the Delphi method.

Cephalalgia : an international journal of headache·2025

Giant cell arteritis (GCA) is a common vasculitis in those over 50. Early diagnosis and prompt treatment are crucial to prevent serious complications like blindness and stroke, despite potential steroid side effects.

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Vasculitis

Background:

  • Giant cell arteritis (GCA) is the most frequent primary systemic vasculitis affecting individuals over 50.
  • Common symptoms include headache (90%), but serious complications like blindness and stroke can occur without it.
  • Nonspecific symptoms like weight loss, fever, and malaise can also dominate the clinical picture.

Purpose of the Study:

  • To review the clinical presentation, diagnosis, and management of Giant Cell Arteritis (GCA).
  • To highlight the importance of prompt diagnosis and treatment to prevent severe outcomes.
  • To discuss current therapeutic strategies and emerging treatment options for GCA.

Main Methods:

  • Review of clinical characteristics of GCA.

Related Experiment Videos

  • Discussion of diagnostic criteria and laboratory findings (ESR > 50 mm/h).
  • Analysis of current treatment protocols, including corticosteroids and steroid-sparing agents.

    • Main Results:

    • Corticosteroids are the primary treatment, initiated promptly upon suspicion.
    • Relapses are common, and steroid side effects are a significant concern in the elderly.
    • Steroid resistance necessitates alternative or adjunctive therapies.

    Conclusions:

    • Prompt initiation of corticosteroids is vital for managing GCA and preventing complications.
    • Emerging evidence suggests efficacy of anti-TNF-alpha agents as steroid-sparing options.
    • New or worsening headaches in patients over 50 warrant immediate GCA evaluation and management.